WILMINGTON, Del., April 27, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Neon Therapeutics, Inc. ("Neon" or the "Company") (NASDAQ GS: NTGN) common stock in connection with the proposed acquisition of Neon by BioNTech SE ("BioNTech") and Endor Lights, Inc. ("Merger Sub"), announced on January 16, 2020 (the "Complaint"). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Neon, its Board of Directors (the "Board"), BioNTech, and Merger Sub, is captioned Franchi v. Neon Therapeutics, Inc., Case No. 1:20-cv-00482 (D. Del.).If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff's counsel, ...Full story available on Benzinga.com